Imigran Recovery works on
treating the root cause of migraine
Just one tablet relieves
the four most common symptoms of a migraine attack: headache, nausea and
sensitivity to light and sound
Gets to work on migraine
headache in as little as 30 minutes
This breakthrough
migraine treatment is now available over the counter from your pharmacist
Ingredients
Imigran Recovery contains
the active ingredient sumatriptan 50 mg which is part of a class of drugs known
as triptans
How
does it work?
Sumatriptan acts like
serotonin, the brain chemical involved in migraine, helping to return blood
vessels to normal and calming the sensory nerves.
The result is that
Imigran Recovery can stop all the main migraine symptoms in their tracks:
headache pain, nausea and sensitivity to light and sound.
Imigran Recovery is
available for those aged 18-65 years with a stable and established pattern of
migraine, who do not receive adequate relief from analgesics
How
does Imigran Recovery work?
Imigran Recovery works on
the root cause of migraine by reducing the painful widening of blood vessels in
the head. The result is that Imigran Recovery can stop the
four most common migraine symptoms in their tracks; headache, sensitivity to
light and sound and nausea.
How
effective is Imigran Recovery?
Imigran Recovery is
highly effective, just one tablet can bring headache relief in around 80% of
migraine sufferers. And it's fast. Headache relief starts in just 30 minutes and
most sufferers get complete relief of the migraine headache and the ability to
return to normal daily activities in two hours.
Why
is Imigran Recovery different to other migraine treatments?
Unlike a painkiller it is
specifically designed to treat migraine and can relieve the four most common
symptoms of a migraine; headache, sensitivity to light and sound and nausea.
Headache relief can start in only 30 minutes and sufferers can get complete
relief of the migraine headache, and the ability to return to normal daily
activities in two hours. For sufferers that could be the difference between
hours spent in bed, or being able get on with their lives.
Is
Imigran Recovery safe?
Imigran Recovery contains
sumatriptan, the first triptan to be developed for migraine. Since the launch of
sumatriptan as a prescription medicine over a decade ago, it has been been used
to treat 800 million migraines worldwide, equivalent to one migraine every
second. The medicine in Imigran Recovery is well tolerated and has an extremely
well established safety profile.
Who
is eligible for Imigran Recovery?
Adults aged between 18
and 65 who have a stable and established pattern of migraine and who do not get
satisfactory relief from analgesics. Pharmacists will diagnose customers using a
Migraine Questionnaire. This process will take place whether or not the migraine
sufferer has been previously diagnosed by a GP. Individuals not suffering from
migraine will be offered appropriate alternative OTC medications, e.g.
analgesics. Those with contraindications, interacting drugs and / or symptoms
not consistent with that of a migraine will be referred to their GP for further
consultation or recommended alternative treatments.
What
age range is Imigran Recovery suitable for?
Imigran Recovery is
suitable for adults aged 18-65. The safety and effectiveness of sumatriptan in
children has not yet been established. Childhood migraine should always be
managed under the care of a GP.
Experience of the use of
sumatriptan in adults aged over 65 years is limited.
How
will the pharmacist determine if I am suitable for Imigran Recovery?
The pharmacist will
determine your eligibility for Imigran Recovery by following the Migraine
Questionnaire that has been developed in conjunction with key opinion leaders in
the field of migraine. The Migraine Questionnaire is designed to diagnose
whether a patient is suffering from a migraine and determine the presence of any
circumstances under which Imigran Recovery is not recommended, e.g. in those
with risk factors for heart disease or with contraindicated conditions such as
high blood pressure.